Literature DB >> 21378560

Mucosal healing in Crohn's disease and ulcerative colitis: what does it tell us?

Ann Flynn1, Sunanda Kane.   

Abstract

PURPOSE OF REVIEW: To provide a critical review of the literature concerning the significance of mucosal healing as a predictor of future clinical and endoscopic course in patients with inflammatory bowel disease. Particular focus is given to articles published within the last year. RECENT
FINDINGS: In patients with Crohn's disease, mucosal healing appears to predict future endoscopic activity. The ability to predict future clinical activity is uncertain, likely limited by present techniques for assessment of clinical activity. Recent studies provide support for escalation of treatment in response to ongoing endoscopic disease activity. However, guidance regarding de-escalation of medical therapy is lacking. In patients with ulcerative colitis, mucosal healing appears to be an important predictor of future endoscopic and clinical activity. Recent evidence suggests that mucosal healing is also an important predictor of long-term outcomes such as need for future colectomy.
SUMMARY: Assessment of mucosal healing is an important tool in the management of patients with inflammatory bowel disease. The pursuit of endoscopic remission has a clear role in the management of patients with ulcerative colitis, but the application of this parameter to the care of patients with Crohn's disease requires further research.

Entities:  

Mesh:

Year:  2011        PMID: 21378560     DOI: 10.1097/MOG.0b013e3283455c8f

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  6 in total

1.  An old herbal medicine with a potentially new therapeutic application in inflammatory bowel disease.

Authors:  Richard Li; Philip Alex; Mei Ye; Ting Zhang; Ling Liu; Xuhang Li
Journal:  Int J Clin Exp Med       Date:  2011-10-29

Review 2.  The digestive neuronal-glial-epithelial unit: a new actor in gut health and disease.

Authors:  Michel Neunlist; Laurianne Van Landeghem; Maxime M Mahé; Pascal Derkinderen; Stanislas Bruley des Varannes; Malvyne Rolli-Derkinderen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-11-20       Impact factor: 46.802

3.  Histological healing favors lower risk of colon carcinoma in extensive ulcerative colitis.

Authors:  Burton I Korelitz; Keith Sultan; Megha Kothari; Leo Arapos; Judy Schneider; Georgia Panagopoulos
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

4.  Quality of Life Is Related to Fecal Calprotectin Concentrations in Colonic Crohn Disease and Ulcerative Colitis, but not in Ileal Crohn Disease.

Authors:  Annika Gauss; Thomas Geiss; Ulf Hinz; Rainer Schaefert; Philipp Zwickel; Anna Zawierucha; Wolfgang Stremmel; Lukas Klute
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

5.  Diagnostic and Clinical Significance of Serum Levels of D-Lactate and Diamine Oxidase in Patients with Crohn's Disease.

Authors:  Jierui Cai; Hong Chen; Meiling Weng; Shuyu Jiang; Jie Gao
Journal:  Gastroenterol Res Pract       Date:  2019-08-19       Impact factor: 2.260

6.  PREDICTIVE FACTORS FOR LOSS OF RESPONSE TO ANTI-TNF IN CROHN'S DISEASE.

Authors:  Byanca Rossetti Moreira Dos Santos; Carlos Henrique Marques Dos Santos; Vitória Rossetti Moreira Dos Santos; Claudia Yanina Garcia Torrez; Daniel Palomares-Junior
Journal:  Arq Bras Cir Dig       Date:  2020-11-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.